173 related articles for article (PubMed ID: 9502298)
1. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.
Walters MC; Patience M; Leisenring W; Rogers ZR; Dinndorf P; Davies SC; Roberts IA; Yeager A; Kurtzberg J; Bunin N; Scott JP; Wall DA; Wayne AS; Wiley J; Darbyshire PJ; Mentzer WC; Smith FO; Sullivan KM
Biol Blood Marrow Transplant; 1997 Dec; 3(6):310-5. PubMed ID: 9502298
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation for sickle cell disease.
Walters MC; Patience M; Leisenring W; Eckman JR; Scott JP; Mentzer WC; Davies SC; Ohene-Frempong K; Bernaudin F; Matthews DC; Storb R; Sullivan KM
N Engl J Med; 1996 Aug; 335(6):369-76. PubMed ID: 8663884
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for sickle cell disease. The United States experience.
Johnson FL; Mentzer WC; Kalinyak KA; Sullivan KM; Abboud MR
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):22-6. PubMed ID: 8311168
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO.
Bernaudin F; Souillet G; Vannier JP; Plouvier E; Lemerle S; Michel G; Bordigoni P; Lutz P; Kuentz M
Bone Marrow Transplant; 1993; 12 Suppl 1():118-21. PubMed ID: 8374551
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.
Adamkiewicz TV; Mehta PS; Boyer MW; Kedar A; Olson TA; Olson E; Chiang KY; Maurer D; Mogul MJ; Wingard JR; Yeager AM
Bone Marrow Transplant; 2004 Sep; 34(5):405-11. PubMed ID: 15247929
[TBL] [Abstract][Full Text] [Related]
6. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.
Panepinto JA; Walters MC; Carreras J; Marsh J; Bredeson CN; Gale RP; Hale GA; Horan J; Hows JM; Klein JP; Pasquini R; Roberts I; Sullivan K; Eapen M; Ferster A;
Br J Haematol; 2007 Jun; 137(5):479-85. PubMed ID: 17459050
[TBL] [Abstract][Full Text] [Related]
7. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.
Vermylen C; Cornu G; Ferster A; Brichard B; Ninane J; Ferrant A; Zenebergh A; Maes P; Dhooge C; Benoit Y; Beguin Y; Dresse MF; Sariban E
Bone Marrow Transplant; 1998 Jul; 22(1):1-6. PubMed ID: 9678788
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
[TBL] [Abstract][Full Text] [Related]
10. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of severe forms of sickle cell anemia with bone marrow allograft: French experience (15 cases). SFGM].
Bernaudin F; Souillet G; Vannier JP; Plouvier E; Lemerle S; Michel G; Bordigoni P; Lutz P; Vernant JP
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):319-23. PubMed ID: 8337153
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
15. Stem cell transplantation for sickle cell disease: can we reduce the toxicity?
Fixler J; Vichinsky E; Walters MC
Pediatr Pathol Mol Med; 2001; 20(1):73-86. PubMed ID: 12673845
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
[TBL] [Abstract][Full Text] [Related]
17. [Results and current indications of bone marrow allograft in sickle cell disease].
Bernaudin F
Pathol Biol (Paris); 1999 Jan; 47(1):59-64. PubMed ID: 10081781
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
20. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]